厦门大学
教师列表
赵颖俊
赵颖俊 教授、博士生导师
国家海外高层次青年人才,福建省“闽江学者”特聘教授,厦门大学南强青年拔尖A类人才
所在单位: 神经科学研究所
办公室: 0592-2880580
电子邮箱: yjzhao@xmu.edu.cn
研究领域
长期致力于衰老相关的神经退行性疾病(如阿尔茨海默症、进行性核上性麻痹)的发病机制、早期诊断及免疫治疗研究,取得了一系列创新成果:1)研发干预AD神经元死亡和丢失的免疫治疗新策略;2)首次揭示遗传变异(rs1768208)导致神经变性及 tau 蛋白病理发生的机制;3)鉴定Aβ 在小胶质细胞上的新受体——TREM2;4)首次发现阿尔茨海默症风险相关因子 SORLA 能抑制 Aβ 的突触毒性;5)发现多个调控 Aβ 产生的新因子。在Neuron(3篇) 、J Exp Med(2篇)、Mol Neurodegener、Signal Transduct Target Ther 以及 J Neurosci 等主流期刊上发表40 余篇 SCI 论文,近 5 年被引用次数>3700, 5篇论文入选 ESI 高被引,单篇论文最高被引用超 1100 次。

学习工作经历

学习经历 2003~2007 厦门大学生命科学学院 学士; 2007~2009 厦门大学生物医学研究院 硕士; 2009~2012 厦门大学药学院和美国Sanford Burnham Prebys 医学研究所 联合培养博士; 工作经历 2012~2018 历任美国Sanford Burnham Prebys 医学研究所博士后、研究助理教授; 2018~至今 厦门大学医学院 教授;

承担项目及获奖

承担的重要课题

1.国家自然科学基金国际(地区)合作与交流项目,2026-01至2028-12,主持

2.国家自然科学基金面上项目,2025-01至2028-12,主持

3.国家实验室攻关课题1,2025-07至2026-08,主持

4.国家实验室攻关课题2, 2024-01至2025-03,主持

5.科技部重点研发计划课题,2021YFA1101401,2021-12至2026-06,骨干

6.国家自然科学基金面上项目,2021-01至2024-12,主持

7.国家海外高层次青年人才项目,2020-2023,主持

获奖及荣誉

1.国家海外高层次青年人才,2020

2.闽江学者特聘教授,2018

3.美国 Joy Cappel 年轻学者奖,2017

代表性成果

1. Zhang C, Ma J, Wu X, Wang X, Huang X, Zheng H*, Zhao Y*. Therapeutic targeting of tauopathies: From druggable biology to precision intervention. Pharmacol Res. 2026;232:108432.

2. Jiang G#, Wang D#, Shao L#, Mao X#, Xiong X#, Zhang D, Chen WN, Yuan H, Wang S, Zhang J, Pina-Crespo J, Zhong L, Zhang YW, Zhang J, Xu H, Ming C, Huang TY, Wu X*, Lei P*, Zhao Y*. MAPT-derived circTau6 induces tau pathogenesis and neurodegeneration by encoding Tau variants. Mol Psychiatry. 2026, doi: 10.1038/s41380-026-03764-4.

3. Wang D, Zhang J, Zhuang Z, Wang Q, Li J, Wang X, Li K, Liu Y, Cao Y, Li L, Zhang Y, Zhao Y, Zhao Y*, Zhao H*, Zhang C*. Vespakinin-M delineates an AMPK/mTOR-arginine-TCA cycle axis to act as an immunometabolic switch in post-stroke microglia. Redox Biol. 2026;94:104210.

4. Zhang D, Zhang W, Ming C, Gao X, Yuan H, Lin X, Mao X, Wang C, Guo X, Du Y, Shao L, Yang R, Lin Z, Wu X, Huang TY, Wang Z, Zhang YW, Xu H, Zhao Y*. P-tau217 correlates with neurodegeneration in Alzheimer's disease and targeting p-tau217 with immunotherapy ameliorates murine tauopathy. Neuron. 2024;112(10):1676-1693.

5. Du Y, Guo T, Hao Y, Li C, Tang L, Li X, Zhang X, Li L, Yao D, Xu X, Si H, Zhang J, Zhao N, Yu T, Zhao Y*, Zhang W*, Xu H. PKCδ serves as a potential biomarker and therapeutic target for microglia-mediated neuroinflammation in Alzheimer's disease. Alzheimers Dement. 2024;20(8):5511-5527.

6. Wang N, Cai L, Pei X, Lin Z, Huang L, Liang C, Wei M, Shao L, Guo T, Huang F, Luo H, Zheng H, Chen XF, Leng L, Zhang YW, Wang X, Zhang J, Guo K, Wang Z*, Zhang H*, Zhao Y*, Xu H. Microglial apolipoprotein E particles contribute to neuronal senescence and synaptotoxicity. iScience. 2024;27(6):110006.

7. Guo X, Yan L, Zhang D, Zhao Y*. Passive immunotherapy for Alzheimer's disease. Ageing Res Rev. 2024; 94:102192.

8. Du Y, Zhao C, Liu J, Li C, Yan Q, Li L, Hao Y, Yao D, Si H, Zhao Y*, Zhang W*. Simplified regimen of combined low-dose rituximab for autoimmune encephalitis with neuronal surface antibodies. Journal of Neuroinflammation. 2022;19(1):309.

9. Guo T#, Pan X#, Jiang G, Zhang D, Qi J, Shao L, Wang Z, Xu H*, Zhao Y*. Downregulating PTBP1 fails to convert astrocytes into hippocampal neurons and to alleviate symptoms in Alzheimer's mouse models. Journal of Neuroscience. 2022;42(38):7309-7317.

10. Zhang H#, Shao L#, Lin Z#, Long QX#, Yuan H#, Cai L, Jiang G, Guo X, Yang R, Zhang Z, Zhang B, Liu F, Li Z, Ma Q, Zhang YW, Huang AL*, Wang Z*, Zhao Y*, Xu H*. APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients. Signal Transduction & Targeted Therapy. 2022;7(1):261.

11. Guo T, Zhang D, Zeng Y, Huang TY*, Xu H*, Zhao Y*. Molecular and cellular mechanisms   underlying   the   pathogenesis   of  Alzheimer's   disease.   Molecular Neurodegeneration. 2020;15(1):40.

12. Zhao Y, Wu X, Li X, Jiang LL, Gui X, Liu Y, Sun Y, Zhu B, Pina-Crespo JC, Zhang M, Zhang N, Chen X, Bu G, An Z, Huang TY, Xu H. TREM2 is a receptor for β- amyloid which mediates microglial function. Neuron. 2018;97(5):1023-31.

13. Du Y#, Zhao Y#, Li C#, Zheng Q, Tian J, Li Z, Huang T, Zhang W, Xu H. Inhibition of PKCδ reduces amyloid-beta levels and reverses Alzheimer Disease phenotypes. The Journal of Experimental Medicine, 2018, DOI: 10.1084/jem.20171193.

14. Huang T#, Zhao Y#, Jiang LL, Li X, Liu Y, Sun Y, Pina-Crespo JC, Zhu B, Masliah E, Willnow TE, Pasquale EB, Xu H. SORLA attenuates EphA4 signaling and β-amyloid-induced neurodegeneration. The Journal of Experimental Medicine. 2017; 214(12): 3669-85.

15. Zhao Y, Li X, Huang T, Jiang LL, Zhang M, Cheng I HJ, Wang X, Bu G, Zhang YW, Wang Q, Xu H. Intracellular-trafficking of TREM2 is regulated by presenilin 1. Experimental Molecular Medicine. 2017; 49, e405.

16. Zhao Y, Tseng IC, Heyser CJ, Rockenstein E, Mante M, Adame A, Zheng Q, Huang T, Wang X, Arslan PE, Chakrabarty P, Wu C, Bu G, Mobley WC, Zhang YW, St George-Hyslop P, Masliah E, Fraser P, Xu H. Appoptosin-Mediated Caspase Cleavage of Tau Contributes to Progressive Supranuclear Palsy Pathogenesis. Neuron. 2015; 87(5):963-75.

学术兼职

中国阿尔茨海默病防治协会理事

中国微循环学会神经免疫专业委员会委员